Range Low Price High Price Comment
30 days $22.66 $25.69 Thursday, 28th Mar 2024 CORT stock ended at $25.19. This is 0.513% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 1.98% from a day low at $25.19 to a day high of $25.69.
90 days $20.87 $33.07
52 weeks $20.87 $34.28

Historical Corcept Therapeutics Incorporated prices

Date Open High Low Close Volume
2023-08-23 $32.00 $32.14 $31.48 $31.81 558 424
2023-08-22 $31.37 $31.71 $31.24 $31.70 416 954
2023-08-21 $31.00 $31.85 $30.98 $31.42 622 330
2023-08-18 $30.33 $30.97 $30.23 $30.93 378 591
2023-08-17 $30.66 $30.91 $30.34 $30.51 417 072
2023-08-16 $30.94 $31.12 $30.45 $30.56 378 407
2023-08-15 $31.14 $31.14 $30.52 $30.96 522 065
2023-08-14 $30.77 $31.15 $30.33 $31.07 637 388
2023-08-11 $30.74 $31.01 $30.52 $30.87 455 361
2023-08-10 $30.17 $30.95 $30.12 $30.70 512 821
2023-08-09 $30.70 $30.70 $29.95 $30.17 660 695
2023-08-08 $30.12 $30.54 $29.94 $30.48 866 637
2023-08-07 $31.56 $31.43 $29.89 $30.23 1 170 300
2023-08-04 $31.24 $31.25 $29.63 $31.19 1 385 270
2023-08-03 $26.00 $31.90 $25.70 $31.24 4 766 014
2023-08-02 $25.00 $25.19 $24.82 $25.01 558 972
2023-08-01 $25.48 $25.87 $24.98 $25.00 905 637
2023-07-31 $25.35 $25.67 $25.09 $25.48 694 921
2023-07-28 $25.33 $25.47 $25.12 $25.35 472 994
2023-07-27 $25.22 $25.26 $24.83 $25.03 437 118
2023-07-26 $24.41 $25.10 $24.41 $25.09 469 297
2023-07-25 $24.28 $24.48 $24.06 $24.37 369 138
2023-07-24 $23.84 $24.42 $23.67 $24.29 546 157
2023-07-21 $23.45 $23.95 $23.35 $23.84 510 376
2023-07-20 $23.15 $23.39 $23.07 $23.33 267 391
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT